Any feedback?
Literature summary extracted from
- Simultaneous preparation of purified plasmalogens and sphingomyelin in human erythrocytes with phospholipase A1 from Aspergillus orizae (2009), Biosci. Biotechnol. Biochem., 73, 2621-2625.
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 3.1.1.32 | Aspergillus oryzae | - |
- |
- |
Source Tissue
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|
Substrates and Products (Substrate)
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 3.1.1.32 | additional information | hydrolysis of diacylphospholipids | Aspergillus oryzae | ? | - |
? |  |
Synonyms
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 3.1.1.32 | phospholipase A1 | - |
Aspergillus oryzae |
| 3.1.1.32 | PLA1 | - |
Aspergillus oryzae |
General Information
| EC Number | General Information | Comment | Organism |
|---|---|---|---|
| 3.1.1.32 | physiological function | simultaneous purification of plasmalogens and sphingomyelin with PLA1 in human erythrocytes. Relative concentration of the plasmalogens after treatment with PLA1 is 92% of phospholipids in the supernatant fraction, and that of sphingomyelin is 97.7% in the precipitate fraction | Aspergillus oryzae |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
